4 completed, 2 not yet recruiting, 1 active not recruiting, 1 terminated. 4 Not applicable, 2 Phase 2, 1 Early Phase 1, 1 Phase 1, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 4 | Completed 2, Active not recruiting 1, Not yet recruiting 1 |
| Phase 2 | 2 | Completed 1, Terminated 1 |
| Early Phase 1 | 1 | Not yet recruiting 1 |
| Phase 1 | 1 | Completed 1 |
| Phase 3 | 1 | Terminated 1 |
Follow cannabigerol: new trials by email Literature Review of cannabigerol trials Research Report on cannabigerol
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| The Effects of Cannabis on Post Operative Recovery After Radical Cystectomy Cannabigerol - Non-metastatic Bladder Cancer | Early Phase 1 | Not yet recruiting | Stanford University | 20 | 2027-07-01 | 2026-07-23 |
| CannaRiver CBD Calm for Anxiety, Sleep, and Well-Being in Adults With Generalized Anxiety Disorder Cannabidiol (CBD) With Cannabinol (CBN) and Cannabigerol (CBG) Oral Tincture (CannaRiver CBD Calm) - Generalized Anxiety Disorder | Not applicable | Not yet recruiting | Associação Pan-Americana Multidisciplinar de Endocanabinologia | 60 | 2026-11-01 | 2026-10-29 |
| The Effects of Cannabigerol on Attention-Deficit/Hyperactivity Disorder Cannabigerol, Placebo - Attention-Deficit/Hyperactivity Disorder | Phase 2 | Completed | University of Arkansas, Fayetteville | 67 | 2024-12-14 | 2026-11-09 |
| A Clinical Study to Assess the Efficacy of Cannabigerol in Patients with Active Rheumatoid Arthritis. Cannabigerol (CBG) - Rheumatoid Arthritis, Inflammatory Disease | Not applicable | Active not recruiting | Raphael Pharma | 12 | 2024-06-03 | 2024-11-21 |
| Cannabidiol 133mg + Cannabigerol 66mg + Tetrahydrocannabinol 4mg Vs Placebo As Adjuvant Treatment in Chronic Migraine - Placebo oral drops, Cannabidiol + Cannabigerol + Tetrahydrocannabinol 133/66/4mg - Chronic Migraine, Headache, Overuse Headache Medication | Phase 2 / Phase 3 | Terminated | Hospital Israelita Albert Einstein | 110 | 2022-10-18 | 2025-02-24 |
| Efficacy and Safety of Hemp-derived, Full Spectrum Cannabigerol (CBG) in Adults Cannabigerol - Health, Subjective, Inflammatory Response | Not applicable | Completed | Formula30A LLC | 69 | 2022-08-01 | 2025-02-27 |
| Acute Effects of Cannabigerol Cannabigerol, Placebo - Focus: To Examine Acute Effects of CBG on Anxiety, Stress, and Cognition | Phase 1 | Completed | Washington State University | 38 | 2022-03-24 | 2026-06-02 |
| Swallowable Cannabigerol Tablets for Sleep Quality In Veterans (Veterans Exploring Cannabigerol for Sleep) Cannabigerol, Placebo - Sleep | Not applicable | Completed | Chris Emerson | 68 | 2021-10-11 | 2022-06-07 |
Anxiety Disorders (1) · Arthritis, Rheumatoid (1) · Attention Deficit Disorder with Hyperactivity (1) · Generalized Anxiety Disorder (1) · Headache (1) · Headache Disorders, Secondary (1) · Marijuana Abuse (1) · Psychological Well-Being (1) · Sleep Initiation and Maintenance Disorders (1)
Associação Pan-Americana Multidisciplinar de Endocanabinologia (1) · Chris Emerson (1) · Formula30A LLC (1) · Hospital Israelita Albert Einstein (1) · Raphael Pharma (1) · Stanford University (1) · University of Arkansas, Fayetteville (1) · Washington State University (1)
United States (6) · Brazil (1) · Puerto Rico (1)
Alexandre O Kaup, MD, PhD (1) · Carrie Cuttler, PhD (1) · Cory Rice, D.O. (1) · Ellen W Leen-Feldner, PhD (1) · Jay Shah, MD (1)